China on Friday (March 17) in the first notification of local cases in which the two Omikon subtypes were infected at the same time.
The latest China Centers for Disease Control and Prevention and Control Center published by the China Centers for Disease Control and Prevention reported the above cases.According to the weekly report, on February 14, in samples collected and submitted to the Third Hospital of Chongqing Medical University, two cases were detected at the same time infected with two types of Omiko strains.
Weekly said that on December 23 last year, the patient had a poor appetite. After six days of fatigue and cough symptoms, it was diagnosed after nucleic acid testing.On January 4 this year, the patient's condition worsened and his body trembled. He had a high fever to 38.9 degrees Celsius and merged to cough. It has not improved after diagnosis and treatment in Yunyang County Traditional Chinese Medicine Hospital in Chongqing.
On January 6 this year, the patient was discharged from the Department of Infectious Diseases of the Third Affiliated Hospital of Chongqing Medical University.From January 6 to February 12, patients with eight nucleic acid tests were positive.
Researchers collected upper respiratory samples from the patients on January 28 and February 7, 2023. Both samples presented the Omikon variant BA.5.2.48 and BF.7.14Specific definition site.In other words, patients infected with Omikon's mutant BA.5.2.48 and BF.7.14 at the same time.
Weekly reported that more than 90%of the main severe acute respiratory syndrome virus currently popular in Chongqing is BA.5.2.48, followed by BF.7.14, about 3.8%.So far, China has no reports about BA.5.2.48 and BF.7.14, especially in Chongqing, the BF.7.14 ratio is relatively low.
Weekly also pointed out that as the risks of the common spread of various variants in one area continue to increase, the monitoring of coronary virus varieties, especially the monitoring of key groups of immune defects, becomes more and more and more and more.important.
